We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Genencor Licenses the ERGO™ Genomics Platform from Integrated Genomics

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Genencor Licenses the ERGO™ Genomics Platform from Integrated Genomics"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Integrated Genomics announced that Genencor the biotechnology division of Danisco A/S that develops enzymes and bio-products, has licensed the ERGO™ bioinformatics software system to characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles, oil and chemical industries.

ERGO™ is a powerful software platform for analyzing genome sequences and performing gene annotations, metabolic reconstructions, and other gene analyses and comparisons.

Optimized for analysis of microorganisms, ERGO™ integrates biological data from genomics, biochemistry, gene expression studies, genetics and literature.

Reaching beyond conventional systems for functional analysis of DNA sequences, Integrated Genomics' platform combines pattern-based analysis with comparative genomics and enables visualization of genes in the contexts of regulation, gene expression data, phylogeny, chromosomal neighborhoods and identification of natural gene fusions.

ERGO™ contains more than 1145 genomes at various stages of completion, as well as the largest available collection of networked cellular pathways.